State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center of Medical School and Gulou Hospital affiliated Medical School, Nanjing University, Nanjing 210061, China.
State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center of Medical School and Gulou Hospital affiliated Medical School, Nanjing University, Nanjing 210061, China.
J Genet Genomics. 2021 Jun 20;48(6):452-462. doi: 10.1016/j.jgg.2021.04.014. Epub 2021 Jun 9.
Airway smooth muscle (ASM) has developed a mechanical adaption mechanism by which it transduces force and responds to environmental forces, which is essential for periodic breathing. Cytoskeletal reorganization has been implicated in this process, but the regulatory mechanism remains to be determined. We here observe that ASM abundantly expresses cytoskeleton regulators Limk1 and Limk2, and their expression levels are further upregulated in chronic obstructive pulmonary disease (COPD) animals. By establishing mouse lines with deletions of Limk1 or Limk2, we analyse the length-sensitive contraction, F/G-actin dynamics, and F-actin pool of mutant ASM cells. As LIMK1 phosphorylation does not respond to the contractile stimulation, LIMK1-deficient ASM develops normal maximal force, while LIMK2 or LIMK1/LIMK2 deficient ASMs show approximately 30% inhibition. LIMK2 deletion causes a significant decrease in cofilin phosphorylation along with a reduced F/G-actin ratio. As LIMK2 functions independently of cross-bridge movement, this observation indicates that LIMK2 is necessary for F-actin dynamics and hence force transduction. Moreover, LIMK2-deficient ASMs display abolishes stretching-induced suppression of 5-hydroxytryptamine (5-HT) but not acetylcholine-evoks force, which is due to the differential contraction mechanisms adopted by the agonists. We propose that LIMK2-mediated cofilin phosphorylation is required for membrane cytoskeleton reorganization that is necessary for ASM mechanical adaption including the 5-HT-evoked length-sensitive effect.
气道平滑肌(ASM)已经开发出一种机械适应机制,通过该机制可以传递力并响应环境力,这对于周期性呼吸至关重要。细胞骨架重排与此过程有关,但调节机制仍有待确定。我们在这里观察到,ASM 大量表达细胞骨架调节剂 Limk1 和 Limk2,并且它们的表达水平在慢性阻塞性肺疾病(COPD)动物中进一步上调。通过建立 Limk1 或 Limk2 缺失的小鼠系,我们分析了突变 ASM 细胞的长度敏感收缩、F/G-肌动蛋白动力学和 F-肌动蛋白库。由于 LIMK1 磷酸化对收缩刺激没有反应,LIMK1 缺陷型 ASM 可产生正常的最大力,而 LIMK2 或 LIMK1/LIMK2 缺陷型 ASMs 则显示约 30%的抑制作用。LIMK2 缺失导致丝切蛋白磷酸化显著减少,同时 F/G-肌动蛋白比降低。由于 LIMK2 的功能独立于横桥运动,因此该观察表明 LIMK2 对于 F-肌动蛋白动力学和因此力传递是必需的。此外,LIMK2 缺陷型 ASMs 显示出拉伸诱导的 5-羟色胺(5-HT)抑制作用的消除,但不是乙酰胆碱引起的力,这是由于激动剂采用的不同收缩机制。我们提出 LIMK2 介导的丝切蛋白磷酸化是膜细胞骨架重排所必需的,这对于 ASM 的机械适应包括 5-HT 诱发的长度敏感效应是必需的。